- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04780425
Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana (SMSCOVID)
A Randomised Parallel-group Multi-centre Study to Evaluate the Effect of Structured Diabetes Self-management Education Versus Standard of Care on Glycaemic Control, Self-efficacy and Quality of Life in Adults in Two Low Resource Settings in Accra Subsequent to COVID-19
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Protocol summary Background: Health systems in low-income countries are overburdened. Corona virus disease-19 (COVID-19) is a pandemic caused by a novel corona virus, Severe acute respiratory syndrome-corona virus 2 (SARS-CoV2) while diabetes is a long-standing global epidemic. COVID-19 further stresses the already overburdened health systems and Public Health measures to contain COVID-19 have severely disrupted health service delivery, particularly routine care. Delivery of diabetes specific education has traditionally been tied to routine visits and delivered in-person. COVID-19 will likely continue to influence service delivery beyond the pandemic, thus alternative ways of delivering diabetes specific education is needed.
Diabetes self-management education is vital to providing diabetes care. It equips patients with critical knowledge and skills for self-care. Recent edicts to stay home in relation to COVID-19 have further heightened the importance of self-care. Appropriate self-management behaviours are associated with lower levels of diabetes related distress, better quality of life and diabetes outcomes overall. Maintaining tight glycaemic control, early in diabetes is associated with fewer microvascular complications and vice versa. Complications of diabetes are prevalent in low resource settings in Africa; partly because of inadequate knowledge on self-care. Diabetes self-management education which is structured and tailor-made for low resource settings may modify self-care behaviors and result in improved self-care, glycaemic control and quality of life.
Aim:
To compare structured diabetes self-management education with standard of care among adults living with type 2 diabetes
Methods:
A prospective parallel-group randomised controlled trial with three months follow-up will be conducted in KBTH Polyclinic/Family Medicine Centre and Weija Gbawe Municipal Hospital, two primary care facilities in Accra. Participants will be individually randomised to standard of care or 6 hours of structured diabetes self-management education (DSME) delivered in person on one day . Each arm will have hundred participants. The standard of care arm will receive unstructured DSME as per existing protocols at each study site. The study population will be adults living with diabetes. The primary outcome, mean glycated haemoglobin (HbA1c ) will be measured at three months.
Expected outcomes:
It is expected that there will be no difference in change in mean glycaemic control, self-efficacy or quality of life at three months between the two arms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Accra, Ghana
- Korle Bu Teaching Hospital
-
Accra, Ghana
- Weija Gbawe Municipal Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Inclusion criteria
- Self-identified as Ghanaian
- Ability to speak either English and or Twi
- be aged > 18 years
- be receiving treatment at the study site as an out-patient
- be willing to accept the 6-hour DSME intervention
- be physically able to participate
- be primarily responsible for their own care
- be ambulant at time of recruitment
- be able to participate in activities in a group setting
- have permanent residence in Greater Accra
Exclusion Criteria:
- known to have cognitive defects
- known to have type I diabetes
- known to be pregnant at the time of recruitment or planning to become pregnant during the study or have given birth less than three months prior to recruitment
- known to have sickle cell disease
- Participating in another intervention study at time of recruitment
- known to have chronic medical complications of diabetes (cardiac, renal, neuropathy, hepatic) or systemic illness at the time of recruitment
- recruitment of a member of the patients household for this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DESMOND
receive usual care plus a structured diabetes self-management education program delivered once over 6hours
|
as previously described
|
|
Active Comparator: USUAL CARE
Receive usual care as per standard treatment guidelines of ghana unstructured education during clinic visits for routine care
|
usual care as per standard treatment guidelines of Ghana unstructured/adhoc diabetes education during clinic visits
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean glaciated heamoglobin (HbA1c) at three months
Time Frame: 3 months
|
change in glycaemic control
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean fasting plasma glucose (FPG) at three months
Time Frame: 3 months
|
change in fasting plasma glucose
|
3 months
|
|
Change in mean fasting blood glucose (FBG) at three months
Time Frame: 3 months
|
change in fasting blood glucose
|
3 months
|
|
Change in mean blood pressure (BP) at three months
Time Frame: 3 months
|
change in blood pressure
|
3 months
|
|
Change in waist circumference (WC) at three months
Time Frame: 3 months
|
change in waist circumference
|
3 months
|
|
Change in neck circumference (NC) at three months
Time Frame: 3 months
|
change in neck circumference
|
3 months
|
|
Change in body weight (BW) at three months
Time Frame: 3 months
|
change in body weight
|
3 months
|
|
Change in problem areas in diabetes (PAID-5) scores
Time Frame: 3 months
|
Change in diabetes related distress at three months, scored from 0 to 4 for each question.
minimum score is 0 maximum score is 20, higher scores mean better outcomes
|
3 months
|
|
Change in mean summary of diabetes self-care activities (SDSCA) score at three months
Time Frame: 3 months
|
change in self-efficacy, min score 0 and max score 7 for each question, higher scores mean better outcomes
|
3 months
|
|
Change in mean WHO quality of life (WHOQoL BREF) score at three months
Time Frame: 3 months
|
change in quality of life
|
3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Roberta Lamptey, FWACP; MSc, Korle Bu Teaching Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KBTH-IRB 100017512020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
ENBIOSIS BIOTECHNOLOGIESAydin Adnan Menderes University; Izmir University of Economics; Buca Seyfi Demirsoy... and other collaboratorsRecruitingType 2 Diabetes | Diabetes Mellitus Type 2Turkey (Türkiye)
-
Instituto Nacional de Ciencias Medicas y Nutricion...Active, not recruiting
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes Mellitus | Type 2 Diabetes | Type2diabetes
-
Endogenex, Inc.Not yet recruitingDiabetes Mellitus, Type 2 | Diabetes | Type 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type2Diabetes
-
University of SalamancaUniversity of Salamanca; Instituto Piaget; Escola Superior de Tecnologia da Saúde...Enrolling by invitationType 2 Diabetes Mellitus | Aging | Hyperglycemia Due to Type 2 Diabetes MellitusPortugal
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Kaiser PermanenteThe Permanente Medical GroupEnrolling by invitationType 2 Diabetes | Type 2 Diabetes Mellitus (T2DM) | Type 2 Diabetes (T2D)United States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Steno Diabetes Center CopenhagenRecruitingDiabetes | Cognitive Impairment | Type 2 Diabetes | Diabetes Mellitus Type 2 | Cognitive Decline | Type 2 Diabetes Mellitus (T2DM)Denmark
Clinical Trials on DESMOND
-
University Hospitals, LeicesterNational Institute for Health Research, United KingdomCompletedType 2 Diabetes MellitusUnited Kingdom
-
Ragae DughmoshHamad Medical Corporation; Qatar University; Qatar National Research Fund; Primary...Not yet recruitingType 2 Diabetes Mellitus (T2DM) | Self-management | Diabetes Self-management
-
Primary Health Care Corporation, QatarNot yet recruiting